Health Data Hub
This sponsor has funded 1 studies across 1 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 104596 | Planned | Definition and validation of algorithms for the identification of specific clinical markers of multiple sclerosis using SNDS data (DIONISOS) | No | No |
PAS by Risk Management Plan (RMP) requirement
Health Data Hub
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
Health Data Hub
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
Health Data Hub
1 Study countries specified are the following:
- France